Recent Press Releases

Liberia-U.S. Clinical Research Partnership Opens Trial to Test Ebola Treatments

Initial Study Will Evaluate Experimental Drug Cocktail ZMapp In partnership with the Liberian government, the National Institute of Allergy and Infectious Diseases (NIAID) today launched a clinical...

Glyconics Appoints Jeremy Williams as Non-Executive Director

Swansea, 24 February 2015 … Glyconics Limited has appointed Jeremy Williams as non-executive director, joining the Board of Directors. Glyconics, an innovative UK diagnostics company, is a...

Chiasma Announces Completion of $70 Million Series E Financing

Newton, Mass. and Jerusalem, Israel, February 27, 2015– Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition...

Alkermes Appoints Mark Namchuk, Ph.D., As Senior Vice President of Research, Pharmaceutical and Nonclinical Development

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced that it has appointed Mark Namchuk, Ph.D., as Senior Vice President of Research, Pharmaceutical and Nonclinical Development. Dr....

Charles River Laboratories Announces Planned Management Changes

Thomas F. Ackerman, Corporate Executive Vice President & Chief Financial Officer, Announces Planned Retirement in 2016 David R. Smith Will Transition to Chief Financial Officer Role Dr. Emily...

Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors

BOSTON, Feb. 27, 2015 /PRNewswire/ -- PureTech, a science and technology R&D company focused on identifying, inventing and commercializing disruptive products and technologies in the healthcare...

Tenax Therapeutics Issues Employment Inducement Award With Appointment of Paula Bokesch, M.D., as Chief Medical Officer

MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care...

Eyevensys Announced Appointment Of Dr Violaine Desort-Henin As Clinical Director

Paris (France), 23rd February 2015 – Eyevensys, an innovative ophthalmic therapy company, announced the appointment Dr. Violaine Desort-Hénin as Clinical Director. In this position, Dr....

TapImmune Inc. (TPIV) Appoints Patrick D. Yeramian, MD, Consulting Medical Director To Lead Phase II Clinical Trials In Triple Negative Breast And HER2/neu Breast Cancer

SEATTLE, Feb. 23, 2015 /PRNewswire/ -- TapImmune, (OTCBB: TPIV), an immunotherapy company specializing in the development of immunotherapeutics for the treatment of cancer including metastatic...

Heliospectra AB Hires Dr. Sue Sisley As Director Of Medicinal Plant Research

GOTEBORG, Sweden and SAN FRANCISCO, Feb. 23, 2015 /PRNewswire/ -- Heliospectra AB (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse cultivation and...

Algatech Names New CEO And Chief Scientist

KIBBUTZ KETURA, Israel, February 23, 2015 /PRNewswire/ -- Algatechnologies, (Algatech) announces the appointment of Ronnie Meninger as CEO. Mr. Hagai Stadler, of Grovepoint (Algatech's major...

Quintiles Appoints Elgar Peerschke as President of Advisory Services

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles today announced the appointment of Elgar Peerschke to serve as president, Advisory Services. In this role, Peerschke is responsible for...

Sirona Biochem Appoints Dr. Martin Gleave To Its Board Of Directors

Vancouver, British Columbia – February 25, 2015 – Sirona Biochem Corp. (TSX-V: SBM / FSE: ZSB) is pleased to announce the appointment of Dr. Martin Gleave to its Board of Directors. Dr....

ProtoKinetix Announces New President and Chief Executive Officer

ST. MARYS, W. Va.--(BUSINESS WIRE)--ProtoKinetix, Incorporated (OTC:PKTX) (www.protokinetix.com) (the "Company" or "ProtoKinetix") announces that a cease trade order issued by the...

Charles River Laboratories Announces Planned Management Changes

2/25/2015 11:03:42 AM Charles River Laboratories International, Inc. (NYSE: CRL) today announced planned management changes which will be implemented over the course of 2015. Chief Financial Officer...

Anatara Lifesciences names new CEO

Anatara Lifesciences (ASX:ANR) has appointed a new CEO and has reported a fivefold increase in its net loss for the half-year ending in December due to spending on commercialisation efforts for lead...

New Director Joins Regeneus (RGS.AX) Board Of Directors

Sydney, Feb 25, 2015 - (ABN Newswire) - Regenerative medicine company, Regeneus Ltd (ASX:RGS) is pleased to announce the appointment of Dr Glen Richards as an independent non-executive director of...

TapImmune Inc. (TPIV) Appoints John Bonfiglio As Strategic Advisor

SEATTLE, Feb. 25, 2015 /PRNewswire/ -- TapImmune Inc. (OTCBB: TPIV) has pleasure in announcing the appointment of John Bonfiglio, Ph.D., MBA as a Strategic Advisor. John is a highly successful...

Tocagen Inc. Appoints Paul Schimmel, Ph.D., To The Board Of Directors

SAN DIEGO, Feb. 25, 2015 /PRNewswire/ -- Tocagen Inc., a clinical-stage cancer-selective immunotherapy company, today announced that Paul Schimmel, Ph.D., Hahn professor of molecular biology and...

Epic Sciences Appoints Chris Bernard As Chief Commercial Officer

SAN DIEGO, Feb. 25, 2015 /PRNewswire/ -- Epic Sciences announced today the appointment of Chris Bernard as chief commercial officer. Mr. Bernard has more than 20 years of experience as a senior...